- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06283979
ET MULTISENTERT, RANDOMISERT (1:1), KONTROLLERT FASE 2-PRØVNING AV STIMULAN VG MED DEBRIDERING OG ET KURS AV SYSTEMISK ANTIBIOTIKA VS STANDARD OF CARE (SOC) FOR BEHANDLING AV SNOMIELITTS ASSOSIERT IV. (BLADE OPU2)
The purpose of this trial is to assess the safety, tolerability and between-group effect size of STIMULAN VG (with debridement) and a course of systemic antibiotics to standard of care (debridement and systemic antibiotics only) for the treatment of osteomyelitis associated stage IV pressure ulcers.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The trial is an open-label, multi-center, randomized (1:1), controlled phase 2 trial in patients diagnosed with stage IV pressure ulcers.
Studietype
Registrering (Antatt)
Fase
- Fase 2
Utvidet tilgang
Kontakter og plasseringer
Studiekontakt
- Navn: Keira Watts, Clinical Research Director
- Telefonnummer: +44 (0) 1782 338 580
- E-post: clinicaltrials@biocomposites.com
Studer Kontakt Backup
- Navn: Daniel Roberts
- E-post: droberts@mcra.com
Studiesteder
-
-
Arizona
-
Phoenix, Arizona, Forente stater, 85032
- Rekruttering
- Advanced Foot Care, LLC
-
Hovedetterforsker:
- Jaminelli Banks, DPM
-
Ta kontakt med:
- Rajashekhar Ittedi
- Telefonnummer: (480) 863-6044
- E-post: rajaittedi123@gmail.com)
-
Ta kontakt med:
- Krishna Sai Penumarthi
- Telefonnummer: (480) 863-6044
- E-post: kspenumarthi@axentrabio.com
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60611
- Rekruttering
- Northwestern University Feinberg School of Medicine
-
Hovedetterforsker:
- Robert Galiano, MD
-
Ta kontakt med:
- Brigid Coles
- Telefonnummer: 312-503-3209
- E-post: brigid.coles@nm.org
-
Ta kontakt med:
- Tarifa Adam
- Telefonnummer: 312-503-3209
- E-post: tarifa.adam@nm.org
-
-
Michigan
-
Detroit, Michigan, Forente stater, 48202
- Rekruttering
- Henry Ford Hospital
-
Hovedetterforsker:
- Aamir Siddiqui, MD
-
Ta kontakt med:
- Sarah Meehan
- E-post: smeehan1@hfhs.org
-
Ta kontakt med:
- Dan Molitor
- E-post: dmolito2@hfhs.org
-
-
Mississippi
-
Jackson, Mississippi, Forente stater, 39216
- Rekruttering
- University of Mississippi Medical Center
-
Ta kontakt med:
- Venkata Seerapu
- E-post: vseerapu@umc.edu
-
Ta kontakt med:
- Laxmi Dhungel
- E-post: idhungel@umc.edu
-
Hovedetterforsker:
- Ian Hoppe, MD
-
-
Missouri
-
Columbia, Missouri, Forente stater, 65201
- Rekruttering
- Missouri Orthopaedic Institute
-
Hovedetterforsker:
- Brett Crist, MD
-
Ta kontakt med:
- Andrew Monhollen
- E-post: am5hf@health.missouri.edu
-
Ta kontakt med:
- Vicki Jones
- E-post: jonesvicki@health.missouri.edu
-
-
Nebraska
-
Omaha, Nebraska, Forente stater, 68198
- Rekruttering
- University of Nebraska Medical Center
-
Ta kontakt med:
- Katie Ostlund
- E-post: katie.ostlund@unmc.edu
-
Ta kontakt med:
- Gabriel Gauthier
- E-post: gabriel.gauthier@unmc.edu
-
Hovedetterforsker:
- James Willcockson, MD
-
-
New Jersey
-
Newark, New Jersey, Forente stater, 07103
- Rekruttering
- Rutgers New Jersey Medical School
-
Ta kontakt med:
- Mehreen Bhatti
- E-post: mb2276@njms.rutgers.edu
-
Ta kontakt med:
- Saharsh Patel
- E-post: ssp186@gsbs.rutgers.edu
-
Hovedetterforsker:
- Alex Wong, MD, FACS
-
-
New York
-
Mineola, New York, Forente stater, 11501
- Rekruttering
- NYU Langone Hospital - Long Island Clinical Research Center
-
Hovedetterforsker:
- Scott Gorenstein, MD
-
Ta kontakt med:
- Monica Benitez
- Telefonnummer: 516 663 9582
- E-post: monica.benitez@nyulangone.org
-
Ta kontakt med:
- Anita Farha
- Telefonnummer: 516 663 9582
- E-post: anita.farhi@nyulangone.org
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Forente stater, 15219
- Rekruttering
- University of Pittsburgh, McGowan Institute for Regenerative Medicine
-
Ta kontakt med:
- Urmila Gnyawali
- Telefonnummer: 412-624-5500
- E-post: usg2@pitt.edu
-
Ta kontakt med:
- Scot King
- Telefonnummer: 412-624-5500
- E-post: scot.king@pitt.edu
-
Hovedetterforsker:
- Sashwati Roy, PhD, MS
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
In order to be eligible to participate in this study, subjects must meet all of the following criteria:
- Presenting with a Stage IV pressure ulcer requiring treatment of excision, bony debridement and flap coverage/primary closure.
- Operative candidate for flap surgery or primary closure.
- Presence of focal osteomyelitis as suggested by imaging to show extent of infection. Acceptable imaging techniques are Magnetic Resonance Imaging or CT scan.
- Adults ≥ 18 years in age at the time of treatment.
- Psychosocially, mentally, and physically able to fully comply with this protocol, including adhering to scheduled visits, treatment plan, completing forms, and other study procedures.
- Ability of the subject or legal authorized representative to provide voluntary, signed and dated informed consent prior to any study-related procedures.
Subjects who meet any of the following criteria will be excluded from participating in this study:
-
Reasons contributing to pressure ulcer cannot be addressed.
-
Severe immunological compromised patients as determined by the clinician.
-
Patients with diffuse or widespread pelvic osteomyelitis that is not amenable to adequate margins for debridement.
-
Patients presenting with head pressure ulcers.
-
Current or recent history (within last 2 years) of active substance abuse (e.g., recreational drugs, narcotics, or alcohol) that in the judgement of the investigator, may compromise the participant's safety/recovery or ability to follow the trial procedures.
-
Current smoker.
-
Diabetic patient with Hba1C level above 9.
-
Allergy to any component of the investigational product, such as calcium sulfate, glycopeptide antibiotics (Vancomycin), or aminoglycoside antibiotics (Gentamicin).
-
Concurrent involvement in a study of another investigational product.
-
Pregnant or planning to become pregnant during study period.
-
Flexion contractures where patient cannot passively get full extension.
-
Uncontrolled muscle spasms.
-
Unable to comply with bedrest restriction or offloading requirements
-
Unable to provide consent.
-
Fecal or urinary incontinence with contamination of the wound.
-
Lower extremity pressure ulcer location that is vascularly compromised as defined by an Ankle Brachial Index ≤ 0.7 mm Hg OR toe brachial index ≤ 0.6 mm OR toe pressure ≤ 40 mm Hg OR transcutaneous oximetry ≤ 40 mm Hg *
-
Investigator considers the participant to be clinically malnourished.
-
Any conditions with known hypercalcemia (> 10.3 mg/dl) or posing a significant risk for developing hypercalcemia (i.e., Hyperparathyroidism).
-
Investigator believes trial participation may compromise safety of the participant or trial results.
- Patients presenting with lower extremity pressure ulcers that are vascularly compromised can be rescreened followed successful revascularization
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Interventional STIMULAN VG
Ulcer bursectomy and debridement and STIMULAN VG insertion into the ulcer cavity. Flap/primary closure. Peri-operative antibiotics. |
Insertion of STIMULAN VG into the ulcer cavity prior to flap/primary closure. Standard of Care. Ulcer bursectomy, debridement and flap/primary closure. Peri-operative antibiotics. |
|
Aktiv komparator: Standard of Care (SoC)
Ulcer bursectomy, debridement and flap/primary closure. Peri-operative antibiotics. |
Standard of Care. Ulcer bursectomy, debridement and flap/primary closure. Peri-operative antibiotics. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Individual patient success and findings at the 8 week follow-up visit
Tidsramme: 8 week
|
An individual patient treatment will be considered a success if there is complete wound closure and healing at the surgical site at two consecutive visits 2 weeks apart. |
8 week
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Beinsykdommer
- Muskel- og skjelettsykdommer
- Infeksjoner
- Beinsykdommer, smittsomme
- Hudsykdommer
- Hudsår
- Hud- og bindevevssykdommer
- Trykksår
- Osteomyelitt
- Health Services Administration
- Helsevesenets kvalitet, tilgang og evaluering
- Kvalitet på helsehjelpen
- Kvalitetsindikatorer, helsehjelp
- Standard for omsorg
Andre studie-ID-numre
- 199723
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .